Showing results (81-90 of 234) with videos related to

Sort By:
Pageof 24
Revue Medicale Suisse|March 26, 2010
[Aspirin as primary prevention for diabetic patients]David Fumeaux, Maria-Elisa Becerra, Jacques Philippe, et al.
Revue Medicale Suisse|April 8, 2015
[Age related dehydroepiandrosterone decrease: clinical significance and therapeutic interest]Nikolaos Samaras, Dimitrios Samaras, Alexandre Forster, et al.
Revue Medicale Suisse|July 10, 2014
[Combined treatment of insulin and GLP-1 analogs: what do we expect?]Bénédicte de Kalbermatten, Jaafar Jaafar, François R Jornayvaz, et al.
European Journal of Biochemistry|March 20, 2004
Inhibition of Drosophila melanogaster acetylcholinesterase by high concentrations of substrateJure Stojan, Laure Brochier, Carole Alies, et al.
Blood Pressure|January 13, 2006
Swiss Hypertension and Risk Factor Program (SHARP): cardiovascular risk factors management in patients with type 2 diabetes in SwitzerlandAntoinette Pechère-Bertschi, Peter Greminger, Lorenzo Hess, et al.
Thrombosis Research|December 3, 2019
Association between polycystic ovary syndrome and venous thromboembolism: A systematic review and meta-analysisKarim Gariani, Justine Hugon-Rodin, Jacques Philippe, et al.
Scientific Reports|June 6, 2015
Varied Probability of Staying Collapsed/Extended at the Conformational Equilibrium of Monomeric Aβ40 and Aβ42Wanling Song, Yuanyuan Wang, Jacques-Philippe Colletier, et al.
Cureus|December 26, 2025
National Trends and Impact of the COVID-19 Pandemic on Trauma Patient Care in the United StatesNzi Jacques Philippe Niamien, Oluwayemisi Oyeleke, Chin-I Cheng, et al.
Behavioural Brain Research|April 2, 2008
Delayed aversive effects of high-dose fentanyl. Prevention by a polyamine-deficient dietLaure Pain, Philippe Oberling, Maud Mainsongeon, et al.
Revue Medicale Suisse|July 28, 2015
[GLP-1 receptor agonists versus SGLT-2 inhibitors in obese type 2 diabetes patients]Ana Rita Forte Marques, Jaafar Jaafar, Bénédicte de Kalbermatten, et al.
Pageof 24